BEST PRACTICES FOR PLANNING A VACCINATION CAMPAIGN FOR AN ENTIRE POPULATION

Similar documents
BEST PRACTICES IN MICROPLANNING FOR CHILDREN OUT OF THE HOUSEHOLD: AN EXAMPLE FROM NORTHERN NIGERIA

GUIDANCE FOR SAMPLING ART CLINICS IN COUNTRIES COMBINING SURVEILLANCE OF PRE-TREATMENT HIV DRUG RESISTANCE AND ACQUIRED HIV DRUG RESISTANCE AT 12 AND

Latent tuberculosis infection

Raising tobacco taxes in Bangladesh in FY : An opportunity for development

WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC,

Summary report on the WHO-EM/WRH/104/E

WEB ANNEX I. REPORT ON COST-EFFECTIVENESS OF IMPLEMENTING AN INDETERMINATE RANGE FOR EARLY INFANT DIAGNOSIS OF HIV

Latent tuberculosis infection

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

Summary report on the WHO-EM/CSR/124/E

preventing suicide Regional strategy on

4. Timing of post-abortion contraception

Operational Guidance on Sharing Seasonal Influenza viruses with WHO Collaborating Centres (CCs) under the Global Influenza Surveillance and Response

DECLARATION ON ACCELERATION OF HIV PREVENTION EFFORTS IN THE AFRICAN REGION

MONITORING HEALTH INEQUALITY

State of InequalIty. Reproductive, maternal, newborn and child health. executi ve S ummary

MONITORING THE BUILDING BLOCKS OF HEALTH SYSTEMS: A HANDBOOK OF INDICATORS AND THEIR MEASUREMENT STRATEGIES

BEST PRACTICES IN MICROPLANNING IN AREAS WITH POOR ACCESS

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc

WHO IMPLEMENTATION TOOL FOR PRE-EXPOSURE PROPHYLAXIS (PrEP) OF HIV INFECTION

Multidrug-/ rifampicinresistant. (MDR/RR-TB): Update 2017

biological agents volume 100 B A review of human carcinogens iarc monographs on the evaluation of carcinogenic risks to humans

Photo Book: Identify Signs of Illness

Intercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net

Volume 10 Cervix Cancer Screening

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

Seasonal Influenza. Zoonotic Influenza. Pandemic Influenza

Operational Guidelines for Transit Strategy during Polio SIAs

WHO Preferred Product Characteristics for Next-Generation Influenza Vaccines

GOOD PHARMACOPOEIAL PRACTICES

WHO/NMH/TFI/11.3. Warning about the dangers of tobacco. Executive summary. fresh and alive

Web Annex 3.1. Adult hepatitis C virus treatment systematic review

WHO Emergency Risk Communication

NATIONAL AIDS PROGRAMME MANAGEMENT A SET OF TRAINING MODULES

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

Checklist for assessing the gender responsiveness of sexual and reproductive health policies. Pilot document for adaptation to national contexts

NATIONAL COORDINATION MECHANISM FOR TOBACCO CONTROL A Model for the African Region

CLINDAMYCIN PALMITATE

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

Eastern Mediterranean Region Framework for health information systems and core indicators for monitoring health situation and health system

Ninth intercountry meeting of national malaria programme managers from HANMAT and PIAM-Net countries

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

EMTRICITABINE AND TENOFOVIR TABLETS

CUTANEOUS LEISHMANIASIS

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

Group B Streptococcus Vaccine Development Technology

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

Second intercountry meeting on the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network

Diabetes. Halt the diabetes epidemic

TECHNICAL UPDATE HIV DRUG RESISTANCE HIV DRUG RESISTANCE SURVEILLANCE GUIDANCE: 2015 UPDATE

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

WHO Library Cataloguing-in-Publication Data. World health statistics 2011.

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

Regional Response Plan for TB-HIV

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

END HEPATITIS BY 2030 PREVENTION, CARE AND TREATMENT OF VIRAL HEPATITIS IN THE AFRICAN REGION: FRAMEWORK FOR ACTION,

IMPLEMENTATION OF THE REVISED GENERAL

Cancer Incidence in Five Continents. Volume VIII

WHO / Christopher Black POLICY BRIEF TRANSITIONING TO AN OPTIMAL PAEDIATRIC ARV FORMULARY: IMPLEMENTATION CONSIDERATIONS

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments

Public health relevant virological features of Influenza A(H7N9) causing human infection in China

Guidelines for treatment of drug-susceptible tuberculosis and patient care

World Immunization Week 2013

Meeting of country focal points for implementation of the PIP framework and expert meeting on pandemic preparedness planning

Guidelines for scaling-up the 100% condom use programme:

Overheads. Complementary Feeding Counselling a training course. World Health Organization

Increasing immunization coverage at the health facility level

WHO PROTOCOL FOR PERFORMANCE LABORATORY EVALUATION OF HCV SEROLOGY ASSAYS

These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017.

BRIEFING TO COMMITTEE A Ebola Outbreak Response IN THE DEMOCRATIC REPUBLIC OF THE CONGO. programme. programme 23 MAY 2018 WORLD HEALTH ASSEMBLY

Regional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007

Afghanistan: WHO and UNICEF estimates of immunization coverage: 2017 revision

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

VPD in Mediterranean Basin and Black Sea: the Polio case

WHO PROTOCOL FOR PERFORMANCE LABORATORY EVALUATION OF HIV SEROLOGY ASSAYS

Overview of Measlescontaining. through UNICEF. Overview of [VACCINE] through UNICEF

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594

Module 9 Strategic information

Measles and Rubella Global Update SAGE 19 October 2017

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

Global Polio Eradication & Endgame Strategy. December 2015

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210

Eighth intercountry meeting of national malaria programme managers from HANMAT and PIAM-Net countries

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

:i iiii ï {:] liii M1!11111[.1i

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)

Republic of Congo: Measles in Pointe-Noire

Innovative Approaches for Eliminating Mother-to-Child Transmission of HIV. Male Champions: Men as Change Agents in Uganda MALE CHAMPIONS

Public Health Laboratories for Alert and Response. A WHO Guidance Document

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093

EBOLA SITUATION REPORT

Table 1: Basic information 2017

YELLOW FEVER UPDATE. DPGH Meeting Dr. Grace Saguti NPO/DPC 13 July 2016

Ebola Virus Diseases

Transcription:

PLANNING A VACCINATION CAMPAIGN FOR AN ENTIRE POPULATION THIS DOCUMENT IS A SUPPLEMENT TO BEST PRACTICES IN MICROPLANNING FOR POLIO ERADICATION.

ACKNOWLEDGEMENTS These best practices documents for polio eradication have been developed from the contributions of many people from all over the world. The people concerned have themselves spent many years striving to eradicate polio, learning from successes and failures to understand what works best and what does not, and quickly making changes to suit the situation. In writing these best practices the aim has been to distil the collective experiences into pages that are easy to read and detailed enough to be adapted for other health programmes. To strive, to seek, to find, and not to yield WHO/POLIO/18.04 (Supplement to Best practices in microplanning for polio eradication - ISBN 978-92-4-151407-1) World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. Best practices for planning a vaccination campaign for an entire population: supplement to Best practices in microplanning for polio eradication. Geneva: World Health Organization; 2018 (WHO/POLIO/18.04). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing. Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-partyowned component in the work rests solely with the user. General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use. Designed by Inís Communication www.iniscommunication.com Printed in Switzerland

PLANNING A VACCINATION CAMPAIGN FOR AN ENTIRE POPULATION THIS DOCUMENT IS A SUPPLEMENT TO BEST PRACTICES IN MICROPLANNING FOR POLIO ERADICATION. INTRODUCTION These best practices of vaccination campaigns for an entire population have been developed from experiences of polio vaccination campaigns conducted in the Congo, Namibia and Tajikistan. Basically, the activities expand on the planning elements used in polio vaccination campaigns for children, but are on a much larger scale and include effective social mobilization because adults are not usually part of vaccination campaigns. Delivery operations include fixed sites, house-to-house teams and transit teams. Above all, to reach the entire population, the campaign s timing and location must be convenient for local communities whose members are often at work during the day and should not have to travel long distances for access. DELIVERY STRATEGY Unlike dealing with young children who will mostly be at home, targeting an entire population means that 50 70% will not be in households during the day, but at work and outside in the streets and countryside. The main delivery strategy should therefore be fixed sites, followed by mobile and transit point teams and door-to-door follow-up, mainly conducted in the evenings when people will be at home. 1

PLANNING AND PREPARATION Resource and logistics plan Plans must be carefully developed and coordinated to capture the whole population. Because the true population numbers will likely not be known, the best approach is to add a population factor of 10 20%, especially in large urban areas. According to the estimated workload, fixed site teams should be composed of: two people to vaccinate and mark fingers one person to record information on the tally sheet one person to mobilize/organize the crowd. Door-to-door teams may consist of only two people. Communications plan The whole population must be engaged through widespread media communication delivered by the community s most senior and respected health officials, who will explain in simple terms the reason for the campaign to ensure clear understanding and demand. Top-level administrators should inform all ministries, large companies, factories, businesses, universities, schools and religious centres, among others, in writing and include the dates and locations for vaccination. The ministry of education should be closely involved so school children can be vaccinated in school, class by class. All health personnel at every level should be informed on how the mass vaccination will be conducted, using various training and media opportunities. Persons responsible for communication should prepare frequently asked questions (FAQs), such as on the vaccination of pregnant women, infants and sick people, and any contraindications. Posters and leaflets should be widely distributed if sufficient time is available; they should be localized in content to inform communities when and where the vaccination will take place. Finger-marking will be applied to the whole population. Preparation Convenient locations and times Operational coordination structures should be established at all levels with maps and schedules, and priorities and responsibilities should be made clear to all. Use maps to decide on convenient locations for posts. List every school, and assign teams to work in the schools. Distribute the maximum number of conveniently-placed teams at posts, easily accessible and visible at markets, health centres, railway stations, churches, headquarters of districts, businesses, factories, universities and major intersections, among others, to optimize access and capture the maximum number of people. 2

Arrange for posts to be open at convenient times (during, before or after working hours). Request cooperation in organizing vaccination posts and managing crowds of clients. Request local support to facilitate the work of teams, providing staff awareness, visible and manageable sites, tables and umbrellas. Operations During the first 2 3 days (fixed posts) Keep posts open from early morning to late evening to access people going to and returning from work. Ensure schools have dedicated teams to work there class by class, with the close cooperation of school teachers. Deploy mobile vaccination teams in addition to fixed teams to regularly scan busy places and vaccinate those unimmunized. Fixed post teams will have a very heavy workload when the entire population is being vaccinated, but vaccination will be much quicker because it mostly concerns adolescents and adults (over 80% of the population will be older children and adults). After the initial 2 3 days Ensure a certain number of fixed teams continue working at the main places of concentration, such as markets, and railway and bus stations. Have house-to-house and mobile teams scan houses, offices and other places for missed persons. Ensure house-to-house teams miss no one, especially children aged under 5 years. Have house-to-house teams continue after working hours to find adults at home. At the end of the vaccination operations Promote independent monitoring that uses established methods, such as lot quality assurance sampling (LQAS). Operational issues A robust system for vaccine and logistics flow, including the provision of quick replenishment, should be planned. Social mobilization and communication must include appropriate strategies for generating awareness and demand. Team working hours should be adapted to market hours, working hours and public transport schedules, for instance, to allow vaccination of the entire population. All teams must start their working days with at least 1000 doses of oral polio vaccine (1500 for fixed teams) and three finger-markers (six for fixed teams). A marker is good for 300 400 markings. House-marking should be simplified to include the date of the visit and whether all occupants are vaccinated. The tally sheet should record children aged under 5 years separately from those aged over 5 years. 3

Conclusions These conclusions are based on operational experiences of expanding the campaign age group to the whole population. Polio campaigns extended to include the whole population have been used both in countries with and without adult transmission. Data collected from outbreaks in the Congo, Namibia, Tajikistan, Somalia, China and the Democratic Republic of the Congo (DRC) show that including older age groups appears to have reduced the duration of polio outbreaks by weeks and the number of vaccination rounds required (Figure 1). Figure 1. Mean duration of polio outbreaks with or without older age groups, 2011 Number 25 20 15 10 5 0 weeks rounds weeks rounds weeks rounds All outbreaks (31) without older with older age groups (7) age groups (24) On most occasions when the whole population was included, the number of vaccinated children aged under 5 years increased compared to campaigns aimed only at children aged under 5 years. Figure 2 shows a significant increase in vaccine uptake for children aged under 5 years when the whole population was included in the campaign. 4

Figure 2. Effect of campaigns involving the whole population on the number of vaccinated children aged under 5 years, 2011 Number of vaccinated children aged <5 years Region Strategy: <5 y Expanded age group Increase/decrease <5 y Tanganyika (KAT) 534 532 659 506 23% Kinshasa 1 764 229 1 892 847 7% Popokabaka (BDD) 30 881 32 140 4% Kikwit (BDD) 618 509 735 177 19% Kimvula (BCG) 13 585 17 984 32% Kasongo (MAN) 253 000 248 516-2% Congo Br 786 292 1 018 867 30% CAR RS3 159 300 183 405 15% DRC Kabondo VDPV area 380 566 488 588 28% KAT: DRC; BDD: Bandundu DRC; BCG: Bas Congo DRC; MAN: Maniema province DRC; Br: Brazzaville; CAR RS3: ; VDPV: vaccine-derived poliovirus 5

www.polioeradication.org